{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:38:30Z","timestamp":1788554310190,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"vor","delay-in-days":104,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.idcr.2019.e00537","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T15:57:22Z","timestamp":1555430242000},"page":"e00537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn\u2019s disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Antonio Riccardo","family":"Buonomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Viceconte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Compare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Iacovazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Zappulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Servillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Borgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.idcr.2019.e00537_bib0005","first-page":"1018","article-title":"Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis","volume":"35","author":"Galli","year":"2017","journal-title":"Clin Exp Rheumatol [Internet]"},{"issue":"July (07)","key":"10.1016\/j.idcr.2019.e00537_bib0010","first-page":"477","article-title":"Aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha\u2013neutralizing antibody: a possible healthcare-associated case?","volume":"24","author":"De","year":"2003","journal-title":"Infect Control Hosp Epidemiol [Internet]"},{"issue":"December (12)","key":"10.1016\/j.idcr.2019.e00537_bib0015","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s00134-003-1867-z","article-title":"Disseminated tuberculosis, pulmonary aspergillosis and cutaneous herpes simplex infection in a patient with infliximab and methotrexate","volume":"29","author":"van der Klooster","year":"2003","journal-title":"Intensive Care Med [Internet]"},{"issue":"September (3)","key":"10.1016\/j.idcr.2019.e00537_bib0020","first-page":"7","article-title":"Disseminated aspergillosis following infliximab therapy in an immunosuppressed patient with Crohn\u2019s disease and chronic hepatitis C: a case study and review of the literature","volume":"7","author":"Alderson","year":"2005","journal-title":"MedGenMed [Internet]"},{"issue":"August","key":"10.1016\/j.idcr.2019.e00537_bib0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jocn.2016.02.009","article-title":"Invasive central nervous system aspergillosis in a patient with Crohn\u2019s disease after treatment with infliximab and corticosteroids","volume":"30","author":"Bourne","year":"2016","journal-title":"J Clin Neurosci [Internet]"},{"issue":"July (7)","key":"10.1016\/j.idcr.2019.e00537_bib0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/14740338.2018.1483330","article-title":"Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis","volume":"17","author":"Buonomo","year":"2018","journal-title":"Expert Opin Drug Saf"},{"issue":"March (1)","key":"10.1016\/j.idcr.2019.e00537_bib0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5152\/eurjrheum.2016.15081","article-title":"Pulmonary aspergillosis after treatment with infliximab in Still\u2019s disease and a literature review of Still\u2019s disease and pulmonary aspergillosis","volume":"5","author":"\u015eeyho\u011flu","year":"2018","journal-title":"Eur J Rheumatol [Internet]"},{"issue":"January","key":"10.1016\/j.idcr.2019.e00537_bib0040","article-title":"Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis","volume":"27","author":"Buonomo","year":"2019","journal-title":"Mult Scler Relat Disord [Internet]"},{"key":"10.1016\/j.idcr.2019.e00537_bib0045","article-title":"Case report a rare case of synchronous mycobacterium tuberculosis, aspergillosis and lung adenocarcinoma in a patient [Internet]","volume":"9","author":"Xu","year":"2016","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.idcr.2019.e00537_bib0050","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciw444","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2019.e00537_bib0055","series-title":"Highlights of prescribing informations [Internet]","first-page":"1","author":"Food and Drug Administration. VFEND\u00ae (voriconazole)","year":"2015"},{"issue":"February (2)","key":"10.1016\/j.idcr.2019.e00537_bib0060","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/AAC.45.2.382-392.2001","article-title":"Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A","volume":"45","author":"Desta","year":"2001","journal-title":"Antimicrob Agents Chemother [Internet]"},{"issue":"September (9)","key":"10.1016\/j.idcr.2019.e00537_bib0065","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00228-017-2284-5","article-title":"Voriconazole-induced QT prolongation among hemato-oncologic patients: clinical characteristics and risk factors","volume":"73","author":"Gueta","year":"2017","journal-title":"Eur J Clin Pharmacol [Internet]"},{"issue":"101 June (6)","key":"10.1016\/j.idcr.2019.e00537_bib0070","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/cpt.620","article-title":"QT interval shortening with isavuconazole: in vitro and in vivo effects on cardiac repolarization","author":"Keirns","year":"2017","journal-title":"Clin Pharmacol Ther [Internet]"},{"issue":"January (1)","key":"10.1016\/j.idcr.2019.e00537_bib0075","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cpdd.285","article-title":"Pharmacokinetic evaluation of CYP3A4-mediated drug-drug interactions of isavuconazole with rifampin, ketoconazole, midazolam, and ethinyl estradiol\/norethindrone in healthy adults","volume":"6","author":"Townsend","year":"2017","journal-title":"Clin Pharmacol Drug Dev [Internet]"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250919300393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250919300393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T15:47:56Z","timestamp":1568821676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250919300393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":15,"alternative-id":["S2214250919300393"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2019.e00537","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2019.e00537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e00537"}}